Cargando…

Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers

Accurate assessment of SARS‐CoV‐2 immunity is critical in evaluating vaccine efficacy and devising public health policies. Whilst the exact nature of effective immunity remains incompletely defined, SARS‐CoV‐2‐specific T‐cell responses are a critical feature that will likely form a key correlate of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scurr, Martin J., Zelek, Wioleta M., Lippiatt, George, Somerville, Michelle, Burnell, Stephanie E. A., Capitani, Lorenzo, Davies, Kate, Lawton, Helen, Tozer, Thomas, Rees, Tara, Roberts, Kerry, Evans, Mererid, Jackson, Amanda, Young, Charlotte, Fairclough, Lucy, Tighe, Paddy, Wills, Mark, Westwell, Andrew D., Morgan, B. Paul, Gallimore, Awen, Godkin, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653009/ https://www.ncbi.nlm.nih.gov/pubmed/34775604 http://dx.doi.org/10.1111/imm.13433

Ejemplares similares

Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
por: Scurr, Martin J., et al.
Publicado: (2022)

Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity
por: Teijeira Crespo, Alicia, et al.
Publicado: (2021)

Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity
por: Burnell, Stephanie E A, et al.
Publicado: (2021)

T‐cell modulation by cyclophosphamide for tumour therapy
por: Hughes, Ellyn, et al.
Publicado: (2018)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
por: Thomson, Amanda, et al.
Publicado: (2021)

High endothelial venules: Help or hindrance in the quest for antitumor immunity?
por: Gallimore, Awen, et al.
Publicado: (2013)

Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver
por: Pembroke, Tom, et al.
Publicado: (2015)

Home Sweet Home: The Tumor Microenvironment as a Haven for Regulatory T Cells
por: Ondondo, Beatrice, et al.
Publicado: (2013)

Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer
por: Scurr, Martin J., et al.
Publicado: (2015)

Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer
por: Betts, Gareth, et al.
Publicado: (2011)

The Dual Role of High Endothelial Venules in Cancer Progression versus Immunity
por: Milutinovic, Stefan, et al.
Publicado: (2021)

The Ussing chamber system for measuring intestinal permeability in health and disease
por: Thomson, Amanda, et al.
Publicado: (2019)

The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design
por: Besneux, Matthieu, et al.
Publicado: (2018)

Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion
por: Hughes, Ellyn, et al.
Publicado: (2020)

Potent T cell agonism mediated by a very rapid TCR/pMHC interaction
por: Boulter, Jonathan M, et al.
Publicado: (2007)

Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
por: Lauder, Sarah Nicol, et al.
Publicado: (2020)

Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T Cells
por: Milutinovic, Stefan, et al.
Publicado: (2022)

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity
por: Simon, Anna Katharina, et al.
Publicado: (2007)

Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes
por: Gallimore, Awen, et al.
Publicado: (1998)

High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression
por: Bento, Diana Costa, et al.
Publicado: (2015)

Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope
por: MacLachlan, Bruce J., et al.
Publicado: (2019)

The paradox of NKp46(+) natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment
por: Pembroke, Tom, et al.
Publicado: (2014)

Molecular characterization of HLA class II binding to the LAG‐3 T cell co‐inhibitory receptor
por: MacLachlan, Bruce J., et al.
Publicado: (2020)

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4(+) T-cell immunity
por: Pembroke, Tom, et al.
Publicado: (2012)

Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion
por: Lauder, Sarah N., et al.
Publicado: (2022)

Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial
por: Scurr, Martin, et al.
Publicado: (2017)

A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas
por: Ondondo, Beatrice, et al.
Publicado: (2015)

CD4(+)CD25(+)FOXP3(+) Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
por: Clarke, Sarah L., et al.
Publicado: (2006)

Interleukin-6 Is Crucial for Recall of Influenza-Specific Memory CD4(+) T Cells
por: Longhi, Maria Paula, et al.
Publicado: (2008)

The link between T cell activation and development of functionally useful tumour-associated high endothelial venules
por: Milutinovic, Stefan, et al.
Publicado: (2023)

Reply: Forkhead box P3-positive regulatory T cells in immune surveillance and cancer
por: Betts, G, et al.
Publicado: (2007)

Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach
por: Lauder, Sarah N., et al.
Publicado: (2021)

Progression of carcinogen‐induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics
por: Ondondo, Beatrice, et al.
Publicado: (2013)

Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report
por: Bradley, Rachel E., et al.
Publicado: (2021)

Highly prevalent colorectal cancer-infiltrating LAP(+) Foxp3(−) T cells exhibit more potent immunosuppressive activity than Foxp3(+) regulatory T cells
por: Scurr, M, et al.
Publicado: (2014)

Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
por: Zelek, Wioleta M., et al.
Publicado: (2020)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4(+) T-cell repertoire selection
por: Cole, David K., et al.
Publicado: (2012)

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
por: Colbeck, Emily Jayne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_25054ah2ao8p7n49splgnfj8pk